Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Other Non-Current Liabilities (2016 - 2019)

Historic Other Non-Current Liabilities for Aptevo Therapeutics (APVO) over the last 5 years, with Q3 2019 value amounting to $12000.0.

  • Aptevo Therapeutics' Other Non-Current Liabilities fell 9656.16% to $12000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $12000.0, marking a year-over-year decrease of 9656.16%. This contributed to the annual value of $200000.0 for FY2018, which is 7275.2% down from last year.
  • Aptevo Therapeutics' Other Non-Current Liabilities amounted to $12000.0 in Q3 2019, which was down 9656.16% from $13000.0 recorded in Q2 2019.
  • Over the past 5 years, Aptevo Therapeutics' Other Non-Current Liabilities peaked at $8.4 million during Q3 2017, and registered a low of $11000.0 during Q1 2019.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $433000.0 (2016), whereas its average is $964066.7.
  • Per our database at Business Quant, Aptevo Therapeutics' Other Non-Current Liabilities soared by 222613.64% in 2017 and then plummeted by 9816.67% in 2019.
  • Over the past 5 years, Aptevo Therapeutics' Other Non-Current Liabilities (Quarter) stood at $71000.0 in 2015, then skyrocketed by 560.56% to $469000.0 in 2016, then surged by 56.5% to $734000.0 in 2017, then plummeted by 72.75% to $200000.0 in 2018, then tumbled by 94.0% to $12000.0 in 2019.
  • Its last three reported values are $12000.0 in Q3 2019, $13000.0 for Q2 2019, and $11000.0 during Q1 2019.